BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11344489)

  • 1. Echocardiographic evaluation of patients cured of childhood cancer: a single center study of 117 subjects who received anthracyclines.
    Bossi G; Lanzarini L; Laudisa ML; Klersy C; Raisaro A; Aricò M
    Med Pediatr Oncol; 2001 Jun; 36(6):593-600. PubMed ID: 11344489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy.
    Leger K; Slone T; Lemler M; Leonard D; Cochran C; Bowman WP; Bashore L; Winick N
    Pediatr Blood Cancer; 2015 Jan; 62(1):123-7. PubMed ID: 25176022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of clinically significant cardiac dysfunction during intermediate dobutamine doses in long-term childhood cancer survivors exposed to anthracyclines.
    Lanzarini L; Bossi G; Laudisa ML; Klersy C; Aricò M
    Am Heart J; 2000 Aug; 140(2):315-23. PubMed ID: 10925349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early diagnosis of anthracycline toxicity in asymptomatic long-term survivors: dobutamine stress echocardiography and tissue Doppler velocities in normal and abnormal myocardial wall motion.
    Yildirim A; Sedef Tunaoglu F; Pinarli FG; Ilhan M; Oguz A; Karadeniz C; Olguntürk R; Oguz D; Kula S
    Eur J Echocardiogr; 2010 Dec; 11(10):814-22. PubMed ID: 20562426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise echocardiography in asymptomatic survivors of childhood cancer treated with anthracyclines: a prospective follow-up study.
    Sieswerda E; Kremer LC; Vidmar S; De Bruin ML; Smibert E; Sjöberg G; Cheung MM; Weintraub RG
    Pediatr Blood Cancer; 2010 Apr; 54(4):579-84. PubMed ID: 20014238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular diastolic function after anthracycline chemotherapy in childhood: relation with systolic function, symptoms, and pathophysiology.
    Bu'Lock FA; Mott MG; Oakhill A; Martin RP
    Br Heart J; 1995 Apr; 73(4):340-50. PubMed ID: 7756067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia.
    Rathe M; Carlsen NL; Oxhøj H
    Pediatr Blood Cancer; 2007 Jun; 48(7):663-7. PubMed ID: 17405151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of dobutamine stress echocardiography in early diagnosis of cardiac toxicity in long-term survivors of asymptomatic children treated with anthracycline].
    Yildirim A; Tunaoğlu FS; Pinarli FG; Ilhan M; Oğuz A; Karadeniz C; Olguntürk R; Oğuz D; Kula S
    Anadolu Kardiyol Derg; 2010 Apr; 10(2):154-62. PubMed ID: 20382616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac function in Wilms' tumor survivors.
    Sorensen K; Levitt G; Sebag-Montefiore D; Bull C; Sullivan I
    J Clin Oncol; 1995 Jul; 13(7):1546-56. PubMed ID: 7602343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insight into the intraventricular pressure gradient as a sensitive indicator of diastolic cardiac dysfunction in patients with childhood cancer after anthracycline therapy.
    Shigemitsu S; Takahashi K; Yazaki K; Kobayashi M; Yamada M; Akimoto K; Tamaichi H; Fujimura J; Saito M; Nii M; Itatani K; Shimizu T
    Heart Vessels; 2019 Jun; 34(6):992-1001. PubMed ID: 30673819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.
    Lipshultz SE; Lipsitz SR; Sallan SE; Dalton VM; Mone SM; Gelber RD; Colan SD
    J Clin Oncol; 2005 Apr; 23(12):2629-36. PubMed ID: 15837978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Echocardiographic Detection of Treatment-Related Cardiac Dysfunction in Adult Survivors of Childhood Cancer: Results From the St. Jude Lifetime Cohort Study.
    Armstrong GT; Joshi VM; Ness KK; Marwick TH; Zhang N; Srivastava D; Griffin BP; Grimm RA; Thomas J; Phelan D; Collier P; Krull KR; Mulrooney DA; Green DM; Hudson MM; Robison LL; Plana JC
    J Am Coll Cardiol; 2015 Jun; 65(23):2511-22. PubMed ID: 26065990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue Doppler imaging in detection of myocardial dysfunction in survivors of childhood cancer treated with anthracyclines.
    Kapusta L; Thijssen JM; Groot-Loonen J; Antonius T; Mulder J; Daniëls O
    Ultrasound Med Biol; 2000 Sep; 26(7):1099-108. PubMed ID: 11053744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late cardiotoxicity after low dose of anthracycline therapy for acute lymphoblastic leukemia in childhood.
    Vandecruys E; Mondelaers V; De Wolf D; Benoit Y; Suys B
    J Cancer Surviv; 2012 Mar; 6(1):95-101. PubMed ID: 21630046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discriminative ability of conventional echocardiography and tissue Doppler imaging techniques for the detection of subclinical cardiotoxic effects of treatment with anthracyclines.
    Kapusta L; Thijssen JM; Groot-Loonen J; van Druten JA; Daniëls O
    Ultrasound Med Biol; 2001 Dec; 27(12):1605-14. PubMed ID: 11839405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late echocardiographic findings following childhood chemotherapy with normal serial cardiac monitoring.
    Johnson GL; Moffett CB; Geil JD; Greenwood MF; Noonan JA
    J Pediatr Hematol Oncol; 1996 Feb; 18(1):72-5. PubMed ID: 8556375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cardiotoxicity by tissue Doppler imaging in childhood leukemia survivors treated with low-dose anthracycline.
    Bayram C; Çetin İ; Tavil B; Yarali N; Ekici F; Isık P; Tunc B
    Pediatr Cardiol; 2015 Apr; 36(4):862-6. PubMed ID: 25577226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac functions evaluated with tissue Doppler imaging in childhood cancers treated with anthracyclines.
    Baysal T; Koksal Y; Oran B; Sen M; Unal E; Cimen D
    Pediatr Hematol Oncol; 2010 Feb; 27(1):13-23. PubMed ID: 20121551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional cardiac wall motion abnormalities during and shortly after anthracyclines therapy.
    Kapusta L; Groot-Loonen J; Thijssen JM; DeGraaf R; Daniëls O
    Med Pediatr Oncol; 2003 Nov; 41(5):426-35. PubMed ID: 14515381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer.
    Lipshultz SE; Lipsitz SR; Mone SM; Goorin AM; Sallan SE; Sanders SP; Orav EJ; Gelber RD; Colan SD
    N Engl J Med; 1995 Jun; 332(26):1738-43. PubMed ID: 7760889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.